TrialPloS one2020

Genome-wide DNA methylation signatures to predict pathologic complete response from combined neoadjuvant chemotherapy with bevacizumab in breast cancer.

Ping-Ching Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.